In a methionine choline-deficient (MCD) or choline-deficient high-fat diet (CD-HFD, 35% fat) non-obese model, RIPK3 deletion reduces steatosis, inflammation, and fibrosis [12,14]. This evidence concerns the gene RIPK3 and steatosis.